pantoprazole sodium · Wyeth Pharms · NDA 020987, 022020
Protonix
Earliest generic entry, as listed · earliest of 3 marketed strengths
7 Dec 2026
2 of 3 marketed strengths have no unexpired patent or exclusivity listed.
Blocked by patent: US 7544370.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7544370 | — | 7 Dec 2026 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Enters 12-month window basis: patent · 022020-0017 Dec 2026
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020987 · 001 · RLD | tablet, delayed release, oral | EQ 40MG BASE | open |
| 020987 · 002 · RLD | tablet, delayed release, oral | EQ 20MG BASE | open |
| 022020 · 001 · RLD | for suspension, delayed release, oral | EQ 40MG BASE | 7 Dec 2026 |
Expired or delisted (1)
- US 7544370 · product · 7 Jun 2026